IL6 and metabolic dysfunction-associated steatotic liver disease: NAFLD rats treated with VD had significantly reduced serum levels AST, GLU, HDL-C, and MCP-1 but increased levels of 25(OH)D3; in addition, IL-6 showed a downward trend in HFD + VD rats compared to HFD + Oil rats (Figures 2A–K).